Published in J Clin Oncol on July 29, 2013
Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol (2014) 1.78
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study. EBioMedicine (2015) 0.92
The association between surgical volume, survival and quality of care. J Thorac Dis (2015) 0.83
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? Neurooncol Pract (2014) 0.82
The price of decreased mortality in the operative management of diverticulitis. Surg Endosc (2014) 0.80
Inequalities in non-small cell lung cancer treatment and mortality. J Epidemiol Community Health (2015) 0.80
Survival analyses of postoperative lung cancer patients: an investigation using Japanese administrative data. Springerplus (2014) 0.80
Update in Lung Cancer 2014. Am J Respir Crit Care Med (2015) 0.79
Improving lung cancer outcomes by improving the quality of surgical care. Transl Lung Cancer Res (2015) 0.78
Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer. Am J Surg (2015) 0.75
Volume-Outcome Relationships in Pediatric Acute Lymphoblastic Leukemia: Association Between Hospital Pediatric and Pediatric Oncology Volume With Mortality and Intensive Care Resources During Initial Therapy. Clin Lymphoma Myeloma Leuk (2016) 0.75
Temporal trends in centralization and racial disparities in utilization of high-volume hospitals for lung cancer surgery. Medicine (Baltimore) (2017) 0.75
Lung cancer: Stage III NSCLC - is it time to centralize care? Nat Rev Clin Oncol (2016) 0.75
Prostate cancer: Case volume and improved outcomes across cancer care. Nat Rev Urol (2016) 0.75
Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia. Br J Haematol (2017) 0.75
Surgeon, not institution, case volume is associated with limb outcomes after lower extremity bypass for critical limb ischemia in the Vascular Quality Initiative. J Vasc Surg (2017) 0.75
Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening. Cancer J (2017) 0.75
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma. J Neurooncol (2017) 0.75
The Advent of Ultra-high Volume Thoracic Surgical Centers in Shanghai. World J Surg (2017) 0.75
Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer. Ann Thorac Surg (2017) 0.75
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol (2011) 4.50
Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol (2008) 3.84
The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol (2007) 3.78
Non-small-cell lung cancer. Lancet (2011) 3.45
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg (2008) 3.21
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer (2008) 3.06
CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. Thorax (2011) 2.88
Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax (2011) 2.81
Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J (2006) 2.74
Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol (2003) 2.59
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial. Thorax (2010) 2.44
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol (2008) 2.38
Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol (2007) 2.29
A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg (2013) 2.26
Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev (2005) 2.24
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax (2010) 2.21
Therapeutic advances in non-small cell lung cancer. Thorax (2011) 2.21
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax (2013) 2.19
Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation (2007) 2.14
Surgical approaches for lung volume reduction in emphysema. Clin Med (2014) 2.14
Clinical upstaging of non-small cell lung cancer that extends across the fissure: implications for non-small cell lung cancer staging. Ann Thorac Surg (2011) 2.14
Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol (2008) 2.12
Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur Heart J (2006) 2.04
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev (2005) 2.03
Do beta-tubulin mutations have a role in resistance to chemotherapy? Lancet Oncol (2004) 1.98
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer (2006) 1.78
Remediastinoscopy: a statistical reinterpretation. J Thorac Cardiovasc Surg (2009) 1.78
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev (2006) 1.75
Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol (2004) 1.70
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer. J Thorac Oncol (2009) 1.65
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer (2006) 1.64
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res (2010) 1.64
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. Eur Urol (2007) 1.60
Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer. J Clin Oncol (2006) 1.60
Debridement alone without decortication can achieve lung re-expansion in patients with empyema: an observational study. Interact Cardiovasc Thorac Surg (2011) 1.53
Knowledge of lung cancer symptoms and risk factors in the U.K.: development of a measure and results from a population-based survey. Thorax (2012) 1.53
A prospective, randomized, controlled trial of the effectiveness of BioGlue in treating alveolar air leaks. J Thorac Cardiovasc Surg (2006) 1.51
Using funnel plots to explore variation in cancer mortality across primary care trusts in South-East England. J Public Health (Oxf) (2008) 1.48
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer (2007) 1.43
Lung cancer resection rate is related to survival. Thorax (2012) 1.42
Treatment of pneumothoraces at a tertiary centre: are we following the current guidelines? Interact Cardiovasc Thorac Surg (2010) 1.40
Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Lung Cancer (2004) 1.40
Oesophageal perforation complicating intraoperative transoesophageal echocardiography: suspicion can save lives. Interact Cardiovasc Thorac Surg (2010) 1.39
Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer (2011) 1.38
Clinical application of direct bronchial ultrasound to visualize and determine endobronchial tumor margins for surgical resection. Ann Thorac Surg (2008) 1.38
Estimating attendance for breast cancer screening in ethnic groups in London. BMC Public Health (2010) 1.35
European guidelines on structure and qualification of general thoracic surgery. Eur J Cardiothorac Surg (2014) 1.35
Ethnicity coding in a regional cancer registry and in Hospital Episode Statistics. BMC Public Health (2006) 1.33
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol (2006) 1.32
Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer (2011) 1.32
The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther (2006) 1.29
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29
Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol (2006) 1.29
Psychosocial aspects of lung cancer. Lung Cancer (2005) 1.28
Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib. J Thorac Oncol (2011) 1.27
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer (2007) 1.23
The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica (2006) 1.23
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. BJU Int (2007) 1.21
Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen (2007) 1.21
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol (2014) 1.20
Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer (2012) 1.19
The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) (2014) 1.16
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Lung Cancer (2010) 1.15
Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England. BJU Int (2009) 1.14
Lung cancer: progress in diagnosis, staging and therapy. Respirology (2010) 1.14
Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001. Eur J Cancer Prev (2007) 1.12
Normal value of carotid intima-media thickness--a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr (2007) 1.11
Innate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signalling. PLoS One (2011) 1.09
Vaginal distribution of Replens and K-Y Jelly using three imaging techniques. Contraception (2008) 1.08
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. BJU Int (2009) 1.06
Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis. J Thorac Cardiovasc Surg (2009) 1.06
Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax (2012) 1.06
Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract (2006) 1.06
Mortality in relation to early retirement in Denmark: a population-based study. Scand J Public Health (2002) 1.06
Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Control (2006) 1.05
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open (2014) 1.05
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer (2007) 1.05
A Drosophila model of Alzheimer's disease. Methods Enzymol (2006) 1.05
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head Neck (2003) 1.04
Midterm clinical and echocardiographic results with patch glue repair of left ventricular free wall rupture. Circulation (2003) 1.04
Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol (2012) 1.03
Recent changes in lung cancer incidence for south Asians: a population based register study. BMJ (2003) 1.03
Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer (2011) 1.03